General Manager, Controller Department Kazuhiko Sueyoshi PLAY LIST from the beginning Financial Results for the Third Quarter of FY2017 Overview of the Financial Results for the 1H of FY2017 Analysis of Factors Causing Changes in Operating Income Sales per Medical Institution Types (Japan)(non-consolidated) Sales by Listed Year of Drugs (Japan) Comparison of Sales Volume (Japan) Sales breakdown by Therapeutic category (North America) North America Business Pipeline FY2017 Earnings Forecasts (IFRS) Sales by Distribution Channels (Japan) Consolidated Financial Highlights-1 Consolidated Financial Highlights-2 Consolidated Financial Highlights-3 Consolidated Financial Date Disclaimer Back Next